Integer (ITGR) Competitors

$111.27
+1.35 (+1.23%)
(As of 05/3/2024 ET)

ITGR vs. MASI, LIVN, TMDX, CNMD, INMD, SLNO, ALKS, PRGO, IMVT, and CBAY

Should you be buying Integer stock or one of its competitors? The main competitors of Integer include Masimo (MASI), LivaNova (LIVN), TransMedics Group (TMDX), CONMED (CNMD), InMode (INMD), Soleno Therapeutics (SLNO), Alkermes (ALKS), Perrigo (PRGO), Immunovant (IMVT), and CymaBay Therapeutics (CBAY). These companies are all part of the "medical" sector.

Integer vs.

Masimo (NASDAQ:MASI) and Integer (NYSE:ITGR) are both mid-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, community ranking, valuation, analyst recommendations, media sentiment, risk, profitability, institutional ownership and earnings.

Integer has lower revenue, but higher earnings than Masimo. Integer is trading at a lower price-to-earnings ratio than Masimo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Masimo$2.05B3.54$81.50M$1.5190.73
Integer$1.63B2.28$90.65M$2.8938.50

In the previous week, Masimo had 1 more articles in the media than Integer. MarketBeat recorded 12 mentions for Masimo and 11 mentions for Integer. Masimo's average media sentiment score of 0.48 beat Integer's score of 0.35 indicating that Integer is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Masimo
4 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral
Integer
7 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Masimo has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500. Comparatively, Integer has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500.

Integer has a net margin of 6.01% compared to Integer's net margin of 3.98%. Integer's return on equity of 13.77% beat Masimo's return on equity.

Company Net Margins Return on Equity Return on Assets
Masimo3.98% 13.77% 5.98%
Integer 6.01%11.25%5.69%

86.0% of Masimo shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 9.7% of Masimo shares are held by company insiders. Comparatively, 2.0% of Integer shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Masimo currently has a consensus price target of $137.43, indicating a potential upside of 0.31%. Integer has a consensus price target of $120.50, indicating a potential upside of 8.30%. Given Masimo's stronger consensus rating and higher probable upside, analysts clearly believe Integer is more favorable than Masimo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Masimo
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43
Integer
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67

Masimo received 78 more outperform votes than Integer when rated by MarketBeat users. Likewise, 64.02% of users gave Masimo an outperform vote while only 63.39% of users gave Integer an outperform vote.

CompanyUnderperformOutperform
MasimoOutperform Votes
452
64.02%
Underperform Votes
254
35.98%
IntegerOutperform Votes
374
63.39%
Underperform Votes
216
36.61%

Summary

Masimo and Integer tied by winning 9 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ITGR vs. The Competition

MetricIntegerElectromedical equipment IndustryMedical SectorNYSE Exchange
Market Cap$3.68B$3.38B$4.96B$17.43B
Dividend YieldN/A1.71%2.86%3.58%
P/E Ratio38.509.75261.6625.59
Price / Sales2.2867.282,426.9712.23
Price / Cash13.8263.0648.4417.50
Price / Book2.444.064.854.92
Net Income$90.65M$91.68M$103.67M$964.63M
7 Day Performance1.54%11.74%3.89%1.73%
1 Month Performance-3.25%-0.92%-3.19%-1.32%
1 Year Performance37.88%5.73%5.73%101.87%

Integer Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MASI
Masimo
3.3586 of 5 stars
$136.95
+2.0%
$137.43
+0.3%
-26.6%$7.11B$2.05B90.705,200Upcoming Earnings
Insider Selling
LIVN
LivaNova
0.6908 of 5 stars
$55.02
+1.9%
$64.40
+17.0%
+35.1%$2.97B$1.15B171.942,900Earnings Report
Analyst Report
News Coverage
TMDX
TransMedics Group
1.9487 of 5 stars
$90.60
+4.7%
$102.00
+12.6%
+75.3%$2.96B$241.62M-117.66584Earnings Report
Analyst Report
Insider Selling
Analyst Revision
News Coverage
CNMD
CONMED
4.978 of 5 stars
$71.31
-1.8%
$120.43
+68.9%
-43.3%$2.20B$1.24B34.964,000Insider Buying
INMD
InMode
3.6211 of 5 stars
$17.37
+1.3%
$32.80
+88.8%
-47.7%$1.46B$492.05M7.55581Analyst Report
Gap Up
SLNO
Soleno Therapeutics
3.4319 of 5 stars
$40.14
+6.9%
$55.60
+38.5%
+1,160.3%$1.30BN/A-13.5233Insider Selling
News Coverage
Gap Down
ALKS
Alkermes
4.8518 of 5 stars
$24.26
+0.8%
$35.38
+45.8%
-16.1%$4.10B$1.66B11.722,100Earnings Report
Analyst Report
Short Interest ↓
Analyst Revision
News Coverage
PRGO
Perrigo
4.7965 of 5 stars
$30.49
+1.4%
$40.67
+33.4%
-12.6%$4.13B$4.66B-304.909,140Upcoming Earnings
Dividend Announcement
IMVT
Immunovant
3.2725 of 5 stars
$28.61
-0.5%
$48.00
+67.8%
+49.9%$4.16BN/A-15.55164Short Interest ↓
Positive News
Gap Up
CBAY
CymaBay Therapeutics
1.4229 of 5 stars
$32.48
flat
$28.65
-11.8%
+216.3%$3.73B$31.07M-33.48101

Related Companies and Tools

This page (NYSE:ITGR) was last updated on 5/4/2024 by MarketBeat.com Staff

From Our Partners